| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8453567 | Lung Cancer | 2018 | 7 Pages |
Abstract
Currently running trials in MPM are mostly in early phases and dominated by systemic therapies. Very few trials evaluate loco-regional therapeutic approaches. The current controversy surrounding the use of surgery and radiotherapy within multimodal therapy strategies will not be answered by these trials in the coming years.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Krisztian Süveg, Paul Martin Putora, Thierry Berghmans, Markus Glatzer, Veljko Kovac, Nikola Cihoric,